<DOC>
	<DOCNO>NCT01735461</DOCNO>
	<brief_summary>Hospitalization kidney stone Inflammatory Bowel Disease ( IBD ) population common , particularly among Crohn 's patient small bowel resection . This patient population experience lifetime occurrence kidney stone formation high 25 % accompany high rate recurrence ( typical rate stone formation ~10 % non IBD population ) . Giving oral calcium use bind oxalate intestine attempt reduce amount oxalate absorb body reduce urinary oxalate level . However , define guideline optimum dose calcium . This study 's primary objective scientifically define appropriate range calcium supplementation reduce level oxalate find urine patient live inflammatory bowel disease .</brief_summary>
	<brief_title>Calcium Supplements Strategy Kidney Stones Prevention Crohn 's Patients</brief_title>
	<detailed_description>The primary objective study establish optimal oral calcium supplementation Crohn 's patient ileal bowel resection . This population high risk calcium oxalate kidney stone , direct consequence extensive gut malabsorption enteric hyperoxaluria . The benefit provide oral calcium patient population ( mean reduce intestinal oxalate absorption ) known , however , appropriate target calcium dose , presently perform empirically . Our goal establish simple , safe practical guideline calcium supplementation .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>1. pathologically confirm diagnosis Crohn 's disease 2. prior ileal resection intact colon ( surgery &gt; 6 month precede involvement study ) 3. hyperoxaluria ( define &gt; 48 mg ( &gt; 0.5 mmol ) per 24 hour urine sample . Patients exclude know kidney stone former . 1. current pregnancy 2. patient 's without baseline hyperoxaluria ( define &gt; 48 mg 0.5mmol per 24 hour urine sample ) 3. patient renal failure assess GFR &lt; 60 4. inability provide inform consent 5. active cancer 6. hyperparathyroidism 7. hyperphosphatemia 8 . &lt; 19 year age</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>